25 XP   0   0   10

Vaxcyte Inc
Buy, Hold or Sell?

Let's analyse Vaxcyte together

PenkeI guess you are interested in Vaxcyte Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vaxcyte Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vaxcyte Inc

I send you an email if I find something interesting about Vaxcyte Inc.

Quick analysis of Vaxcyte (30 sec.)










What can you expect buying and holding a share of Vaxcyte? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.9%

What is your share worth?

Current worth
$11.44
Expected worth in 1 year
$14.09
How sure are you?
35.3%

+ What do you gain per year?

Total Gains per Share
$2.65
Return On Investment
3.9%

For what price can you sell your share?

Current Price per Share
$68.31
Expected price per share
$54.97 - $82.04
How sure are you?
50%

1. Valuation of Vaxcyte (5 min.)




Live pricePrice per Share (EOD)

$68.31

Intrinsic Value Per Share

$-90.39 - $-108.01

Total Value Per Share

$-78.95 - $-96.57

2. Growth of Vaxcyte (5 min.)




Is Vaxcyte growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$509.7m$745.5m59.4%

How much money is Vaxcyte making?

Current yearPrevious yearGrowGrow %
Making money-$97.5m-$59.6m-$37.8m-38.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Vaxcyte (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#48 / 1031

Most Revenue
#753 / 1031

Most Profit
#989 / 1031

Most Efficient
#202 / 1031

What can you expect buying and holding a share of Vaxcyte? (5 min.)

Welcome investor! Vaxcyte's management wants to use your money to grow the business. In return you get a share of Vaxcyte.

What can you expect buying and holding a share of Vaxcyte?

First you should know what it really means to hold a share of Vaxcyte. And how you can make/lose money.

Speculation

The Price per Share of Vaxcyte is $68.31. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vaxcyte.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vaxcyte, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $11.44. Based on the TTM, the Book Value Change Per Share is $0.66 per quarter. Based on the YOY, the Book Value Change Per Share is $1.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vaxcyte.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.67-2.4%-0.93-1.4%-0.52-0.8%-0.47-0.7%-0.47-0.7%
Usd Book Value Change Per Share-1.50-2.2%0.661.0%1.542.3%0.671.0%0.671.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.50-2.2%0.661.0%1.542.3%0.671.0%0.671.0%
Usd Price Per Share62.80-50.30-29.47-30.47-30.47-
Price to Earnings Ratio-9.41--15.23--14.21--21.04--21.04-
Price-to-Total Gains Ratio-41.96--167.67-5.14--120.14--120.14-
Price to Book Ratio5.49-4.38-6.60-6.37-6.37-
Price-to-Total Gains Ratio-41.96--167.67-5.14--120.14--120.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share68.31
Number of shares14
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.660.67
Usd Total Gains Per Share0.660.67
Gains per Quarter (14 shares)9.269.43
Gains per Year (14 shares)37.0437.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10372703828
20746407566
301111010113104
401481380151142
501851750188180
602222120226218
702592490264256
802962860302294
903333230339332
1003703600377370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.011.00.035.3%6.011.00.035.3%6.011.00.035.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.016.05.9%1.00.016.05.9%1.00.016.05.9%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%6.011.00.035.3%6.011.00.035.3%6.011.00.035.3%

Fundamentals of Vaxcyte

About Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Fundamental data was last updated by Penke on 2024-03-22 00:13:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vaxcyte Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vaxcyte earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vaxcyte Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y--452.4%+452.4%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Vaxcyte is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • -12.8% Return on Assets means that Vaxcyte generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vaxcyte Inc:

  • The MRQ is -12.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-7.1%-5.7%
TTM-7.1%YOY-11.2%+4.1%
TTM-7.1%5Y-9.2%+2.1%
5Y-9.2%10Y-9.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-12.5%-0.3%
TTM-7.1%-12.2%+5.1%
YOY-11.2%-11.2%+0.0%
5Y-9.2%-13.3%+4.1%
10Y-9.2%-14.6%+5.4%
1.1.3. Return on Equity

Shows how efficient Vaxcyte is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • -14.6% Return on Equity means Vaxcyte generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vaxcyte Inc:

  • The MRQ is -14.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-7.8%-6.8%
TTM-7.8%YOY-12.5%+4.7%
TTM-7.8%5Y-8.9%+1.1%
5Y-8.9%10Y-8.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.6%-16.0%+1.4%
TTM-7.8%-15.8%+8.0%
YOY-12.5%-13.9%+1.4%
5Y-8.9%-18.2%+9.3%
10Y-8.9%-19.1%+10.2%

1.2. Operating Efficiency of Vaxcyte Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vaxcyte is operating .

  • Measures how much profit Vaxcyte makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vaxcyte Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Vaxcyte is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vaxcyte Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y-5.554-5.554
10Y-7.396-7.396

1.3. Liquidity of Vaxcyte Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vaxcyte is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.54 means the company has $7.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vaxcyte Inc:

  • The MRQ is 7.541. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.095. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.541TTM15.095-7.554
TTM15.095YOY14.291+0.804
TTM15.0955Y11.129+3.966
5Y11.12910Y11.1290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5413.987+3.554
TTM15.0954.440+10.655
YOY14.2915.569+8.722
5Y11.1296.158+4.971
10Y11.1296.492+4.637
1.3.2. Quick Ratio

Measures if Vaxcyte is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • A Quick Ratio of 12.16 means the company can pay off $12.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vaxcyte Inc:

  • The MRQ is 12.155. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 23.951. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.155TTM23.951-11.796
TTM23.951YOY17.375+6.577
TTM23.9515Y14.748+9.203
5Y14.74810Y14.7480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.1553.653+8.502
TTM23.9514.158+19.793
YOY17.3755.515+11.860
5Y14.7486.012+8.736
10Y14.7486.206+8.542

1.4. Solvency of Vaxcyte Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vaxcyte assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vaxcyte to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Vaxcyte assets are financed with 11.9% credit (debt) and the remaining percentage (100% - 11.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vaxcyte Inc:

  • The MRQ is 0.119. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.073. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.119TTM0.073+0.046
TTM0.073YOY0.099-0.027
TTM0.0735Y0.252-0.179
5Y0.25210Y0.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1190.336-0.217
TTM0.0730.330-0.257
YOY0.0990.267-0.168
5Y0.2520.367-0.115
10Y0.2520.378-0.126
1.4.2. Debt to Equity Ratio

Measures if Vaxcyte is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vaxcyte to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.5% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vaxcyte Inc:

  • The MRQ is 0.135. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.079. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.079+0.056
TTM0.079YOY0.111-0.032
TTM0.0795Y0.110-0.031
5Y0.11010Y0.1100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1350.376-0.241
TTM0.0790.398-0.319
YOY0.1110.334-0.223
5Y0.1100.431-0.321
10Y0.1100.476-0.366

2. Market Valuation of Vaxcyte Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vaxcyte generates.

  • Above 15 is considered overpriced but always compare Vaxcyte to the Biotechnology industry mean.
  • A PE ratio of -9.41 means the investor is paying $-9.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vaxcyte Inc:

  • The EOD is -10.240. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.414. Based on the earnings, the company is expensive. -2
  • The TTM is -15.232. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.240MRQ-9.414-0.826
MRQ-9.414TTM-15.232+5.819
TTM-15.232YOY-14.205-1.027
TTM-15.2325Y-21.042+5.809
5Y-21.04210Y-21.0420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.240-2.697-7.543
MRQ-9.414-2.422-6.992
TTM-15.232-2.709-12.523
YOY-14.205-4.116-10.089
5Y-21.042-6.257-14.785
10Y-21.042-6.478-14.564
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vaxcyte Inc:

  • The EOD is -9.960. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.157. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.960. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.960MRQ-9.157-0.803
MRQ-9.157TTM-17.960+8.804
TTM-17.960YOY-18.047+0.086
TTM-17.9605Y-29.043+11.082
5Y-29.04310Y-29.0430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.960-3.344-6.616
MRQ-9.157-2.939-6.218
TTM-17.960-3.486-14.474
YOY-18.047-5.592-12.455
5Y-29.043-8.464-20.579
10Y-29.043-8.872-20.171
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vaxcyte is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.49 means the investor is paying $5.49 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vaxcyte Inc:

  • The EOD is 5.970. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.488. Based on the equity, the company is overpriced. -1
  • The TTM is 4.376. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.970MRQ5.488+0.482
MRQ5.488TTM4.376+1.112
TTM4.376YOY6.603-2.226
TTM4.3765Y6.365-1.989
5Y6.36510Y6.3650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.9702.198+3.772
MRQ5.4882.042+3.446
TTM4.3762.121+2.255
YOY6.6032.907+3.696
5Y6.3653.682+2.683
10Y6.3654.114+2.251
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vaxcyte Inc.

3.1. Institutions holding Vaxcyte Inc

Institutions are holding 96.623% of the shares of Vaxcyte Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc13.1110.0686142133651363280.9684
2023-12-31BlackRock Inc7.91070.01378575847115459615.558
2023-12-31Vanguard Group Inc7.79680.011684523711681252.0295
2023-12-31RA Capital Management, LLC7.27927.7403789125400
2023-12-31HHG PLC6.43990.26156981376-79212-1.1219
2023-12-31Wellington Management Company LLP4.08820.05194431920-166792-3.6269
2023-12-31Capital Research Global Investors3.17330.05323440107759802.2585
2023-12-31State Street Corporation3.12660.010433895282442697.7663
2023-12-31T. Rowe Price Associates, Inc.2.47010.0226267782226017010.7613
2023-12-31Geode Capital Management, LLC1.82040.0131973506983925.2473
2023-12-31AllianceBernstein L.P.1.76650.04631915047-28783-1.4807
2023-12-31Driehaus Capital Management LLC1.54451.2668167436835048426.4739
2023-12-31Fred Alger Management, LLC1.54070.56591670189-423116-20.2128
2023-09-30BRAIDWELL LP1.49392.60921619553-102800-5.9686
2023-12-31Jennison Associates LLC1.36170.06911476154-278537-15.8738
2023-12-31Westfield Capital Management Company, LP1.34270.5328145559345167744.9915
2023-12-31T. Rowe Price Investment Management,Inc.1.14940.05091246041414133.4378
2023-12-31Orbimed Advisors, LLC1.06371.4462115309114594314.4907
2023-12-31Pictet Asset Manangement SA1.06010.07961149209-325573-22.076
2023-12-31COMMODORE CAPITAL LP1.01476.036110000000
Total 70.554120.949676486341+1722564+2.3%

3.2. Funds holding Vaxcyte Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds SMALLCAP World A2.87840.27233120376759802.4957
2024-01-31Vanguard Total Stock Mkt Idx Inv2.76870.0145300149434354012.925
2024-02-29iShares Russell 2000 ETF2.33920.30022535923-414-0.0163
2024-01-31Vanguard Small Cap Index2.24880.1318243786025696211.7824
2023-12-31Vanguard Health Care Inv2.18250.3201236595300
2023-12-31Janus Henderson US SMID Cap Growth1.49311.497161868900
2023-12-31Janus Henderson Triton D1.49311.4906161868900
2024-02-29SPDR® S&P Biotech ETF1.37371.38821489182278401.9051
2024-01-31Fidelity Select Health Care1.30511.32111414800148001.0571
2024-01-31Vanguard Small Cap Growth Index Inv1.25230.3036135759314210011.6907
2024-01-31Fidelity Growth Compy Commingled Pl O1.23610.1334134004813989911.6568
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.20810.09731309637121090.9332
2024-01-31Fidelity Advisor Growth Opps M1.04250.4325113014300
2024-01-31Fidelity Select Biotechnology0.92541.55311003180-21300-2.0791
2023-12-31T. Rowe Price New Horizons0.8920.2454966994834549.4454
2023-12-31US Small-Cap Growth II Equity Comp0.8920.2446966994834549.4454
2023-12-31Janus Henderson Global Life Sciences D0.8611.1911933381-154657-14.2143
2023-12-31Janus Henderson Global Life Sciences0.8611.1967933381-154657-14.2143
2023-12-31Fidelity Small Cap Index0.860.2304932352113171.2287
2024-02-29iShares Russell 2000 Growth ETF0.84750.59749187934350.0474
Total 28.960512.961331395462+860862+2.7%

3.3. Insider Transactions

Insiders are holding 0.912% of the shares of Vaxcyte Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-18Andrew GuggenhimeSELL800069.02
2024-03-01Elvia CowanSELL1167874.08
2024-03-01Grant PickeringSELL261673.7
2024-03-01Jim WassilSELL300073.71
2024-02-01Grant PickeringSELL261673.91
2024-02-01Jim WassilSELL300073.88
2024-02-01Mikhail EydelmanSELL166773.87
2024-01-31Heath LukatchSELL500071.5
2024-01-29Grant PickeringSELL3000066.03
2024-01-29Heath LukatchSELL400067.5
2024-01-23Grant PickeringSELL1500063.92
2024-01-18Andrew GuggenhimeSELL800060.73
2024-01-02Mikhail EydelmanSELL166763.93
2024-01-02Jim WassilSELL300063.91
2024-01-02Heath LukatchSELL1300063.76
2024-01-02Grant PickeringSELL261663.89
2023-12-26Grant PickeringSELL1500061.7
2023-12-18Andrew GuggenhimeSELL800060.18
2023-12-07Mikhail EydelmanSELL1000056.5
2023-11-24Grant PickeringSELL1500049.09

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vaxcyte Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.4970.662-326%1.544-197%0.673-322%0.673-322%
Book Value Per Share--11.44311.580-1%4.702+143%5.111+124%5.111+124%
Current Ratio--7.54115.095-50%14.291-47%11.129-32%11.129-32%
Debt To Asset Ratio--0.1190.073+64%0.099+20%0.252-53%0.252-53%
Debt To Equity Ratio--0.1350.079+70%0.111+21%0.110+23%0.110+23%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---1.668-0.928-44%-0.515-69%-0.470-72%-0.470-72%
Free Cash Flow Per Share---1.715-0.841-51%-0.407-76%-0.397-77%-0.397-77%
Free Cash Flow To Equity Per Share---1.6890.635-366%1.580-207%0.653-359%0.653-359%
Gross Profit Margin--1.0161.004+1%1.000+2%1.001+2%1.001+2%
Intrinsic Value_10Y_max---108.012--------
Intrinsic Value_10Y_min---90.394--------
Intrinsic Value_1Y_max---3.331--------
Intrinsic Value_1Y_min---3.267--------
Intrinsic Value_3Y_max---15.718--------
Intrinsic Value_3Y_min---14.891--------
Intrinsic Value_5Y_max---34.990--------
Intrinsic Value_5Y_min---31.985--------
Market Cap7405350480.000+8%6808022400.0005452922400.000+25%3194241720.000+113%3303510607.059+106%3303510607.059+106%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio5.970+8%5.4884.376+25%6.603-17%6.365-14%6.365-14%
Pe Ratio-10.240-9%-9.414-15.232+62%-14.205+51%-21.042+124%-21.042+124%
Price Per Share68.310+8%62.80050.300+25%29.465+113%30.473+106%30.473+106%
Price To Free Cash Flow Ratio-9.960-9%-9.157-17.960+96%-18.047+97%-29.043+217%-29.043+217%
Price To Total Gains Ratio-45.642-9%-41.961-167.666+300%5.144-916%-120.140+186%-120.140+186%
Quick Ratio--12.15523.951-49%17.375-30%14.748-18%14.748-18%
Return On Assets---0.128-0.071-45%-0.112-13%-0.092-29%-0.092-29%
Return On Equity---0.146-0.078-47%-0.125-14%-0.089-39%-0.089-39%
Total Gains Per Share---1.4970.662-326%1.544-197%0.673-322%0.673-322%
Usd Book Value--1240468000.0001255332750.000-1%509741750.000+143%554049235.294+124%554049235.294+124%
Usd Book Value Change Per Share---1.4970.662-326%1.544-197%0.673-322%0.673-322%
Usd Book Value Per Share--11.44311.580-1%4.702+143%5.111+124%5.111+124%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---1.668-0.928-44%-0.515-69%-0.470-72%-0.470-72%
Usd Free Cash Flow---185879000.000-91166750.000-51%-44111250.000-76%-43070705.882-77%-43070705.882-77%
Usd Free Cash Flow Per Share---1.715-0.841-51%-0.407-76%-0.397-77%-0.397-77%
Usd Free Cash Flow To Equity Per Share---1.6890.635-366%1.580-207%0.653-359%0.653-359%
Usd Market Cap7405350480.000+8%6808022400.0005452922400.000+25%3194241720.000+113%3303510607.059+106%3303510607.059+106%
Usd Price Per Share68.310+8%62.80050.300+25%29.465+113%30.473+106%30.473+106%
Usd Profit---180801000.000-97541250.000-46%-59658250.000-67%-48983117.647-73%-48983117.647-73%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.4970.662-326%1.544-197%0.673-322%0.673-322%
 EOD+5 -3MRQTTM+5 -25YOY+8 -225Y+10 -2210Y+10 -22

4.2. Fundamental Score

Let's check the fundamental score of Vaxcyte Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.240
Price to Book Ratio (EOD)Between0-15.970
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.155
Current Ratio (MRQ)Greater than17.541
Debt to Asset Ratio (MRQ)Less than10.119
Debt to Equity Ratio (MRQ)Less than10.135
Return on Equity (MRQ)Greater than0.15-0.146
Return on Assets (MRQ)Greater than0.05-0.128
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vaxcyte Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.255
Ma 20Greater thanMa 5069.735
Ma 50Greater thanMa 10070.922
Ma 100Greater thanMa 20063.528
OpenGreater thanClose68.220
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,407,917
Total Liabilities167,449
Total Stockholder Equity1,240,468
 As reported
Total Liabilities 167,449
Total Stockholder Equity+ 1,240,468
Total Assets = 1,407,917

Assets

Total Assets1,407,917
Total Current Assets1,095,954
Long-term Assets311,963
Total Current Assets
Cash And Cash Equivalents 397,451
Short-term Investments 682,776
Net Receivables 3,607
Other Current Assets 12,120
Total Current Assets  (as reported)1,095,954
Total Current Assets  (calculated)1,095,954
+/-0
Long-term Assets
Property Plant Equipment 110,623
Long Term Investments 162,675
Long-term Assets Other 37,562
Long-term Assets  (as reported)311,963
Long-term Assets  (calculated)310,860
+/- 1,103

Liabilities & Shareholders' Equity

Total Current Liabilities145,338
Long-term Liabilities22,111
Total Stockholder Equity1,240,468
Total Current Liabilities
Short-term Debt 7,113
Accounts payable 14,587
Other Current Liabilities 123,638
Total Current Liabilities  (as reported)145,338
Total Current Liabilities  (calculated)145,338
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt22,111
Long-term Liabilities  (as reported)22,111
Long-term Liabilities  (calculated)22,111
+/-0
Total Stockholder Equity
Common Stock98
Retained Earnings -924,392
Accumulated Other Comprehensive Income 179
Other Stockholders Equity 2,164,583
Total Stockholder Equity (as reported)1,240,468
Total Stockholder Equity (calculated)1,240,468
+/-0
Other
Capital Stock98
Cash and Short Term Investments 1,080,227
Common Stock Shares Outstanding 95,365
Liabilities and Stockholders Equity 1,407,917
Net Debt -368,227
Net Invested Capital 1,240,468
Net Working Capital 950,616
Property Plant and Equipment Gross 154,583
Short Long Term Debt Total 29,224



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
65,698
162,533
416,248
403,816
392,826
382,351
358,054
354,068
324,337
402,717
411,619
412,065
1,006,178
1,008,163
1,502,819
1,496,057
1,407,917
1,407,9171,496,0571,502,8191,008,1631,006,178412,065411,619402,717324,337354,068358,054382,351392,826403,816416,248162,53365,698000
   > Total Current Assets 
0
0
0
61,723
158,591
413,057
400,835
389,004
324,714
301,532
302,949
256,348
342,223
363,725
369,759
942,555
840,674
1,310,317
1,295,434
1,095,954
1,095,9541,295,4341,310,317840,674942,555369,759363,725342,223256,348302,949301,532324,714389,004400,835413,057158,59161,723000
       Cash And Cash Equivalents 
0
0
0
58,976
154,791
410,046
397,048
386,200
198,939
150,996
112,044
68,985
201,741
238,173
366,203
834,657
949,853
531,033
545,134
397,451
397,451545,134531,033949,853834,657366,203238,173201,74168,985112,044150,996198,939386,200397,048410,046154,79158,976000
       Short-term Investments 
0
0
0
0
0
0
0
0
122,180
141,120
166,532
176,985
132,900
116,326
83,825
96,719
441,587
756,031
720,550
682,776
682,776720,550756,031441,58796,71983,825116,326132,900176,985166,532141,120122,18000000000
       Net Receivables 
0
0
0
0
0
1,000
800
300
0
400
5,700
1,200
100
700
700
1,000
1,300
2,400
5,324
3,607
3,6075,3242,4001,3001,0007007001001,2005,70040003008001,00000000
       Other Current Assets 
0
0
0
2,747
3,800
3,011
3,787
2,804
3,595
9,416
24,373
10,378
7,582
9,226
7,533
11,179
18,636
23,253
1,299
12,120
12,1201,29923,25318,63611,1797,5339,2267,58210,37824,3739,4163,5952,8043,7873,0113,8002,747000
   > Long-term Assets 
0
0
0
3,975
3,942
3,191
2,981
3,822
57,637
56,522
51,119
67,989
60,494
47,894
42,306
63,623
167,489
192,502
200,623
311,963
311,963200,623192,502167,48963,62342,30647,89460,49467,98951,11956,52257,6373,8222,9813,1913,9423,975000
       Property Plant Equipment 
0
0
0
3,391
3,339
2,753
2,539
3,272
6,022
6,311
6,933
35,912
36,259
34,732
32,834
31,648
34,863
34,426
27,764
110,623
110,62327,76434,42634,86331,64832,83434,73236,25935,9126,9336,3116,0223,2722,5392,7533,3393,391000
       Long Term Investments 
0
0
0
0
0
0
0
0
49,754
48,835
39,735
27,117
17,697
6,862
3,977
26,549
127,815
153,726
168,564
162,675
162,675168,564153,726127,81526,5493,9776,86217,69727,11739,73548,83549,75400000000
       Other Assets 
0
0
0
0
603
438
442
550
1,861
1,376
4,451
4,960
6,538
6,300
5,495
5,426
4,811
4,350
0
0
004,3504,8115,4265,4956,3006,5384,9604,4511,3761,8615504424386030000
> Total Liabilities 
0
0
0
172,071
24,685
33,038
39,741
46,983
55,414
41,029
48,112
40,319
43,174
45,119
52,754
52,565
63,392
69,443
93,341
167,449
167,44993,34169,44363,39252,56552,75445,11943,17440,31948,11241,02955,41446,98339,74133,03824,685172,071000
   > Total Current Liabilities 
0
0
0
11,052
24,522
32,894
39,612
46,861
55,016
40,704
47,461
28,716
27,249
30,467
39,309
40,525
52,747
60,216
85,558
145,338
145,33885,55860,21652,74740,52539,30930,46727,24928,71647,46140,70455,01646,86139,61232,89424,52211,052000
       Short-term Debt 
0
0
0
161
0
0
0
0
833
710
613
5,276
6,578
6,644
6,426
5,910
5,947
5,986
6,028
7,113
7,1136,0285,9865,9475,9106,4266,6446,5785,2766137108330000161000
       Accounts payable 
0
0
0
3,376
2,650
2,556
10,685
29,785
31,864
23,697
25,713
6,758
4,801
7,039
5,485
9,795
11,615
16,266
15,704
14,587
14,58715,70416,26611,6159,7955,4857,0394,8016,75825,71323,69731,86429,78510,6852,5562,6503,376000
       Other Current Liabilities 
0
0
0
7,676
21,872
30,338
28,927
17,076
22,319
16,297
21,135
16,682
15,870
16,784
27,398
24,820
35,185
37,964
63,826
123,638
123,63863,82637,96435,18524,82027,39816,78415,87016,68221,13516,29722,31917,07628,92730,33821,8727,676000
   > Long-term Liabilities 
0
0
0
161,019
163
144
129
122
398
325
651
11,603
15,925
14,652
13,445
12,040
10,645
9,227
7,783
22,111
22,1117,7839,22710,64512,04013,44514,65215,92511,603651325398122129144163161,019000
       Long term Debt Total 
0
0
0
0
629
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000006290000
       Other Liabilities 
0
0
0
0
163
144
129
122
103
100
98
96
93
92
89
9
7
5
0
0
0057989929396981001031221291441630000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
100
0
400
500
500
500
300
200
500
0
0
0
0
000050020030050050050040001000000000
> Total Stockholder Equity
0
0
0
-106,373
137,848
383,210
364,075
345,843
326,937
317,025
305,956
284,018
359,543
366,500
359,311
953,613
944,771
1,433,376
1,402,716
1,240,468
1,240,4681,402,7161,433,376944,771953,613359,311366,500359,543284,018305,956317,025326,937345,843364,075383,210137,848-106,373000
   Common Stock
0
0
0
7
33
54
54
54
54
55
56
56
59
62
64
82
84
97
98
98
989897848264625956565554545454337000
   Retained Earnings Total Equity000-582,5880-444,076-386,159-337,627-298,641-270,078-243,463-219,784-198,5640000000
   Accumulated Other Comprehensive Income 
0
0
0
-2,982
-3,366
-3,496
-3,831
0
-47
-8
-12
-241
-833
-904
-657
-361
47
-2,521
-2,290
179
179-2,290-2,52147-361-657-904-833-241-12-8-470-3,831-3,496-3,366-2,982000
   Capital Surplus 
0
0
0
0
3,516
0
0
544,353
546,714
560,441
575,990
582,844
697,944
753,501
803,980
0
1,527,228
0
0
0
0001,527,2280803,980753,501697,944582,844575,990560,441546,714544,353003,5160000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
5,949
277,670
127,213
141,863
544,353
164,363
202,387
221,922
582,844
697,944
753,501
803,980
1,476,018
1,527,228
2,086,727
2,148,499
2,164,583
2,164,5832,148,4992,086,7271,527,2281,476,018803,980753,501697,944582,844221,922202,387164,363544,353141,863127,213277,6705,949000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-10,171
Gross Profit-10,171-10,171
 
Operating Income (+$)
Gross Profit-10,171
Operating Expense-382,870
Operating Income-393,041-393,041
 
Operating Expense (+$)
Research Development332,341
Selling General Administrative60,700
Selling And Marketing Expenses10,171
Operating Expense382,870403,212
 
Net Interest Income (+$)
Interest Income62,907
Interest Expense-0
Other Finance Cost-0
Net Interest Income62,907
 
Pretax Income (+$)
Operating Income-393,041
Net Interest Income62,907
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-402,266-383,816
EBIT - interestExpense = -393,041
-402,266
-402,266
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-393,041-402,266
Earnings Before Interest and Taxes (EBITDA)-382,870
 
After tax Income (+$)
Income Before Tax-402,266
Tax Provision-0
Net Income From Continuing Ops-402,266-402,266
Net Income-402,266
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses393,041
Total Other Income/Expenses Net-9,225-62,907
 

Technical Analysis of Vaxcyte
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vaxcyte. The general trend of Vaxcyte is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vaxcyte's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vaxcyte Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 82.04.

The bearish price targets are: 65.97 > 59.13 > 54.97.

Tweet this
Vaxcyte Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vaxcyte Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vaxcyte Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vaxcyte Inc. The current macd is -1.14786556.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vaxcyte price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vaxcyte. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vaxcyte price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vaxcyte Inc Daily Moving Average Convergence/Divergence (MACD) ChartVaxcyte Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vaxcyte Inc. The current adx is 15.35.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vaxcyte shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vaxcyte Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vaxcyte Inc. The current sar is 66.06.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vaxcyte Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vaxcyte Inc. The current rsi is 45.26. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Vaxcyte Inc Daily Relative Strength Index (RSI) ChartVaxcyte Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vaxcyte Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vaxcyte price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Vaxcyte Inc Daily Stochastic Oscillator ChartVaxcyte Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vaxcyte Inc. The current cci is -50.38444703.

Vaxcyte Inc Daily Commodity Channel Index (CCI) ChartVaxcyte Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vaxcyte Inc. The current cmo is -10.69059908.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vaxcyte Inc Daily Chande Momentum Oscillator (CMO) ChartVaxcyte Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vaxcyte Inc. The current willr is -70.03994674.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vaxcyte is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vaxcyte Inc Daily Williams %R ChartVaxcyte Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vaxcyte Inc.

Vaxcyte Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vaxcyte Inc. The current atr is 2.46910207.

Vaxcyte Inc Daily Average True Range (ATR) ChartVaxcyte Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vaxcyte Inc. The current obv is 63,754,968.

Vaxcyte Inc Daily On-Balance Volume (OBV) ChartVaxcyte Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vaxcyte Inc. The current mfi is 48.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vaxcyte Inc Daily Money Flow Index (MFI) ChartVaxcyte Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vaxcyte Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Vaxcyte Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vaxcyte Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.255
Ma 20Greater thanMa 5069.735
Ma 50Greater thanMa 10070.922
Ma 100Greater thanMa 20063.528
OpenGreater thanClose68.220
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vaxcyte with someone you think should read this too:
  • Are you bullish or bearish on Vaxcyte? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vaxcyte? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vaxcyte Inc

I send you an email if I find something interesting about Vaxcyte Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vaxcyte Inc.

Receive notifications about Vaxcyte Inc in your mailbox!